About Norgine

Norgine is a European specialist pharmaceutical company that acquires, develops and commercialises innovative medicines for patients who need them. Founded in 1906, the company focuses on gastroenterology, hepatology and rare diseases, working through a network of partnerships to bring late stage products to market across Europe, Australia and New Zealand. With over 1,400 employees and operations in all major European markets, Norgine helps 25 million patients worldwide every year. The company's agile infrastructure and century of experience enable it to move quickly from licensing to launch, ensuring that transformative treatments reach healthcare systems and the people who depend on them.